🏆 Thrilled to announce we have been awarded the Robert G. Edwards Prize Paper Award from Reproductive BioMedicine Online🏆 The award celebrates our groundbreaking achievement of the world's first babies conceived with our automated ICSI robot 👶 💫 At Overture Life we are passionate about revolutionizing the fertility space through automation and cutting-edge technology. We want to extend our gratitude to RBMO for the recognition of the best paper published in 2023. #ivf #fertilityjourney #automation #ICSI #RBMO To read the full article:
Overture Life
Biotechnology Research
New York, New York 7,015 followers
We are making IVF more accessible than ever. An embryology lab in a box that pushes IVF to a whole new level.
About us
Overture Life is a clinical-stage biotechnology company whose mission is to automate assisted reproductive processes to improve IVF pregnancy outcomes through process automation and non-invasive embryo selection. Its revolutionary technologies help standardize fertility treatments, by simplifying techniques and optimizing resources to make reproductive technologies more affordable, reliable, and accessible. Founded by recognized global leaders in embryo genetic testing and assisted reproduction, Overture is backed by Khosla Ventures, Felicis Ventures, Octopus Ventures and GV, and maintains offices in the U.S. and Spain.
- Website
-
https://overture.life/
External link for Overture Life
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- New York, New York
- Type
- Privately Held
- Founded
- 2017
- Specialties
- biotechnology and medicine
Locations
-
Primary
Get directions
117 East 57th Street
New York, New York 10022, US
-
Get directions
Avenida Europa, 4
Alcobendas, Madrid 28050, ES
Employees at Overture Life
Updates
-
Happy International Women's Day! Today, we honor the incredible achievements and contributions of women around the globe. At Overture Life, we're proud to be part of a movement that empowers women to take control of their reproductive health journey. In the fertility space, every step forward is a step towards empowering women to make informed decisions about their futures. From innovative technologies to compassionate care, we're committed to breaking down barriers and reimagining access to fertility treatment. Let’s continue building a more inclusive world for all! #IWD #empowerment #fertility #ART #inclusion
-
Great show! Our Board Member Jessica McCreadie, from Octopus Ventures, speaks about health tech and the current state of IVF. She talks about how Overture is bringing automation to the space to eliminate the variability of biological results and democratize access to fertility treatments. 🔸 Women on average need to undertake 2.5+ IVF cycles to reach pregnancy. 🔸 Lack of standardization of manual process causes a 20%+ variability of results 🔸Median age for new mums continues to increase: 30 yrs of age in the US and 29.4 in the EU
🎉🪩 New show drop! Jessica McCreadie from Octopus Ventures take a bow, this new episode of HealthTech Hour is so good (even if I do say so and I have a slight bias…) 🤭 We covered so much including: 🔨 What investors like and don’t like, what to avoid - CLUE: focus on your problem and your pathway not your technology! ⚖️ Importance of diversity and equality in VC, finance and in startup culture - from Jess’ unique perspective having been in finance her entire career and how Octopus Ventures are a force for change in this area 📱software as an enabler of healthcare solutions - neuromodulation (Parasym ) and automation in IVF (Overture Life ) get special mentions 🔜 upcoming future trends in healthcare Pleased we got this out before half term really kicked in (if you know, you know!) Thanks to Sarah Swolfs for making this happen and as ever thanks to Arthur Perkins and Johann Ilgenfritz ! Apple pod link below but it’s on all platforms and the video is on YouTube #newshow #podcast #health #investment https://lnkd.in/dy3afksN
HealthTech Hour: Ep86: Jess McCreadie, Principal Investor at Octopus Ventures - tech as an enabler of change, what investors like and don't, importance of diversity of gender and background in VC/startups, future health business trends auf Apple Podcasts
podcasts.apple.com
-
🚨 Great read on Healthcare Digital 🚨 Thank you for shedding light on the pressing issue of declining fertility rates. In the article Hans, our CEO, shares how “at Overture Life, we want to improve access and standardize procedures to improve pregnancy outcomes and lower costs, thereby democratizing access to fertility.” Data reveals women and families in the USA on average want 2.4 children but end up having 1.6. "Through automation, we can raise the bar across the board” and reduce the gap. We strive to standardize the most complex procedures and eliminate variability and improve biological outcomes. To read the full article: https://lnkd.in/dwTa2f57
Hans Gangeskar and Overture Life: Revolutionizing IVF with Automation
healthcare-digital.com
-
Thrilled to share that our CEO, Hans Gangeskar, was featured in a recent Yahoo News article about groundbreaking innovation in the fertility space. In the article, Hans commented on the importance of leveraging technology to enable the next phase of IVF. At Overture Life we are pioneering the path to the democratization of access to best-in-class fertility treatments with our automation solutions for the embryology lab. Read the full article https://lnkd.in/db2K3d9Y
Three-person babies, artificial wombs and other groundbreaking fertility treatments in the works
news.yahoo.com
-
Overture Life reposted this
Excited to share that we have been chosen as one of the world’s most promising impact startups by Norrsken and its partners Khosla Ventures, Obama Foundation, Bill & Melinda Gates Foundation, Atomico, EQT Foundation, amongst others. The Impact/100 selects a cohort of startups from diverse fields and regions. Featured startups have positive global impact as an intrinsic and non-negotiable part of their business model, driving measurable progress against the 17 United Nations Sustainable Development Goals. We are thrilled for the feature and this recognition motivates us to continue our journey to reimagine the #IVF space and enable the next phase of #assistedreproduction Thank you Norrsken and Niklas Adalberth
-
-
Excited to share that we have been chosen as one of the world’s most promising impact startups by Norrsken and its partners Khosla Ventures, Obama Foundation, Bill & Melinda Gates Foundation, Atomico, EQT Foundation, amongst others. The Impact/100 selects a cohort of startups from diverse fields and regions. Featured startups have positive global impact as an intrinsic and non-negotiable part of their business model, driving measurable progress against the 17 United Nations Sustainable Development Goals. We are thrilled for the feature and this recognition motivates us to continue our journey to reimagine the #IVF space and enable the next phase of #assistedreproduction Thank you Norrsken and Niklas Adalberth
-